Intralesional injection therapy for Peyronie's disease.
Hellstrom
Wayne J G
WJ
Tulane University School of Medicine, Department of Urology, New Orleans, LA, USA.
Cockerham
Yolanda R
YR
D000779:Anesthetics, Local / Q000008:administration & dosage / Q000627:therapeutic use; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D015552:Injections, Intralesional; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000627:therapeutic use*; D008012:Lidocaine / Q000008:administration & dosage / Q000627:therapeutic use; D008297:Male; D010411:Penile Induration / Q000601:surgery*; D011994:Recombinant Proteins; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D014700:Verapamil / Q000008:administration & dosage / Q000627:therapeutic use*
D000779:Anesthetics, Local; D020533:Angiogenesis Inhibitors; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D014665:Vasodilator Agents; D008012:Lidocaine; D014700:Verapamil